Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Received: 14 March 2021
Accepted: 12 May 2021
First Online: 21 June 2021
: Ethical approval will be applied for at the University in Kiel, Schleswig-Holstein. In addition, all participants need to obtain an ethical approval within their country or a documented waiver stating there is no requirement for ethical approval. The ethical approval or the documented waiver must be sent to the Study Management Team. As only anonymised data will be reported and the data is recorded as part of routine care, a requirement for patient consent is not expected. It is however the role of the coordinator to ensure that patient consent is not required in his/her jurisdiction.There are no interventions in this study other than the effort required by EMS personnel or systems to report the required information to the study. There is no reported or estimated risk related to participation in this study, and since the treatment is not changed, there is no increased risk involved for the patient. The benefit to the patient is that countries get to benchmark their results and compare with best practice.Important protocol changes will be communicated to all participating registries. Changes will also be shared with other relevant parties.
: Each participating registry will obtain ethical approval in their own country or organise a documented waiver and forward this document to the Study Management Team (SMT) when requested.
: The authors declare that they have no competing interests.